ArticleClinical and experimental medicine2026
Salivary proteomics of patients with type 2 diabetes identify potential biomarkers for diabetes and highlight significant role of immune response.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Diabetes is a global public health problem, causing diverse complications, consequently compromising patient quality of life. Salivary proteome is affected by pathological conditions, however, the contributions of salivary proteins to diabetes are not fully understood. Hence, this study aimed to evaluate the changes of salivary proteomes in patients with diabetes through LC-MS/MS technology. Proteomics analysis identified 1186 differently expressed proteins (DEPs) in saliva from patients with diabetes versus normal control, among which 851 were upregulated and 335 were downregulated. Functional analysis highlighted the enrichments in immune response and immune response-related signaling pathways. Further comparative analysis between mild and severe diabetes identified 386 DEPs including 262 upregulated and 124 downregulated. Functional annotation enriched significantly in immune response and calcium signaling pathway. By K-means and weighted gene co-expression network analysis, five candidate proteins were selected for further verification. Notably, ELISA and correlation analysis discovered that CAMK2D was increased in the diabetic saliva in a stage-dependent manner, and salivary CAMK2D content was positively correlated to blood glucose and glycosylated hemoglobin; while SPRR2A was decreased, and negatively correlated to blood glucose and glycosylated hemoglobin. Therefore, CAMK2D and SPRR2A may participate in the pathology and aggravation of diabetes by regulating immune response through calcium signaling pathway, and may serve as potential salivary biomarkers and therapeutic targets for diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.